Autoimmune diabetes is characterized by an early mononuclear in®ltration of pancreatic islets and later selective autoimmune destruction of insulin-producing b cells. Lymphocyte homing receptors have been considered candidate targets to prevent autoimmune diabetes. L-selectin (CD62L) is an adhesion molecule highly expressed in naive T and B cells. It has been reported that blocking Lselectin in vivo with a speci®c antibody (Mel-14) partially impairs insulitis and diabetes in autoimmune diabetes-prone non-obese diabetic (NOD) mice. In the present study we aimed to elucidate whether genetic blockade of leukocyte homing into peripheral lymph nodes would prevent the development of diabetes. We backcrossed L-selectin-de®cient mice onto the NOD genetic background. Surprisingly NOD/L-selectin-de®cient mice exhibited unaltered islet mononuclear in®ltration, timing of diabetes onset and cumulative incidence of spontaneous diabetes when compared to L-selectin-suf®cient animals. CD4, CD8 T cells and B cells were present in islet in®ltrates from 9-week-old L-selectin-suf®cient and -de®cient littermates. Moreover, total splenocytes from wild-type, heterozygous or NOD/L-selectin-de®cient donor mice showed similar capability to adoptively transfer diabetes into NOD/SCID recipients. On the other hand, homing of activated, cloned insulin-speci®c autoaggressive CD8 T cells (TGNFC8 clone) is not affected in NOD/L-selectin-de®cient recipients. We conclude that L-selectin plays a small role in the homing of autoreactive lymphocytes to regional (pancreatic) lymph nodes in NOD mice.
Introduction
The non-obese diabetic (NOD) mouse constitutes one of the best models for the study of autoimmune diabetes or insulindependent diabetes mellitus (IDDM) (1, 2) . The b cell destruction in NOD mice is T cell dependent (3±5), and leads to impaired insulin production and, as a result, overt diabetes. Mononuclear in®ltration of pancreatic tissue, including perivascular and peri-islet in®ltrates, consists of T cells, B cells, macrophages and dendritic cells, and begins early in life of NOD female mice (at 3±5 weeks of age). With age, this in®ltration becomes more prevalent and invasive, exhibited as intra-islet in®ltration or insulitis, but diabetes is not observed before 12 weeks of age (2, 6) . Since autoaggressive lymphocytes must home to the islets in order to cause the autoimmune destruction of b cells, they need to extravasate from blood vessels surrounding the islets before reaching the target cells.
Multiple adhesion molecules are involved in the interaction of lymphocytes with in¯amed endothelium. These consist of ligand±receptor pairs constituted by the adhesion molecules and their receptors. Lymphocyte recruitment to tissues is regulated and restricted to physiological situations in which tissue in¯ammation is required (7) . L-selectin (CD62L) is expressed on all leukocytes and, among other functions, mediates the binding of naive lymphocytes to endothelial cells present at high endothelial venules (HEV) in peripheral lymph nodes (PLN); this permits the rolling of lymphocytes along the endothelium in injured or in¯amed tissue (8±10). L-selectin mediates extravasation of naive CD4 T cells into PLN (9) and is also important for the normal migration of some memory lymphocytes (10) .
L-selectin has a lectin-like structure which interacts with its speci®c glycoprotein-ligands expressed in HEV (14±16). There are at least four speci®c ligands for L-selectin described, one of which is CD34 (14) . These four ligands are glycoproteins synthesized by the HEV in PLN and mesenteric lymph nodes (14) .
L-selectin-de®cient mice on the C57BL/6 background (11) show an impaired primary T cell response when measured shortly after immunization. Secondary (memory) and humoral responses are not impaired in these mice. These ®ndings suggest that after several doses of immunogen and longer periods after immunization, lymphocytes may encounter the antigen in an L-selectin-independent fashion, via entrance, for example, through the spleen where they become memorytype lymphocytes. Interestingly, blockade of L-selectin by in vivo administration of anti-L-selectin mAb antibody (Mel-14) into NOD females from week 5 of age to week 12 impaired the development of peri-insulitis and adoptively transferred diabetes (17) . This previous work (17) did not, however, address the role of L-selectin in the development of spontaneous diabetes from naive lymphocytes, but used instead primed diabetogenic lymphocytes in adoptive transfer experiments. Moreover, it could be argued that prolonged in vivo administration of an anti-L-selectin-blocking antibody might exert a depleting effect on the L-selectin-expressing lymphocyte population (17, 18, 19, 23) . We therefore decided to assess whether L-selectin is a key factor required to prime autoaggressive lymphocytes in peripheral/pancreatic lymph nodes by using L-selectin ±/± NOD mice.
Methods

Generation and genotyping of NOD
mice were previously generated in our laboratory by gene-targeted disruption and homozygosity for the mutation was obtained by intercrossing on the C57BL/6 background (11). L-selectin KO mice were backcrossed 6, 10 and 13 times onto the NOD background (N7, N11 and N14 generations respectively). Mice were selected at N6 to be homozygous for the 15 Idd (IDDM described susceptibility loci in mice) NOD alleles tested (Idd1±15) (20) for further backcrossing and intercrossing to provide experimental mice. Screening for the L-selectin mutation was performed by PCR analysis using the following primers: Neo1: 5¢-CAT TGA ACA AGA TGG ATT GCA CGC-3¢; Neo2: 5¢-CTC GAT GCG ATG TTT CGC TTG GTG-3¢ [PCR product: 450 bp, present in KO mice or mice heterozygous (HTZ) for the mutation]; F3MEX6: 5¢-CAG CCC CAT TCC AAT CAA ATC-3¢; R1ME-6: 5¢-GAT GAC CAG TTT CCA GAT GCT CC-3¢ (PCR product: 250 bp in wild-type mice or HTZ mice; absent in KO mice). PCR conditions for both sets of primers were 95°C 1 min, 55°C 2 min and 72°C 3 min, 30 cycles.
Genotyping for the Idd loci was performed using PCR primers speci®c for different loci that are polymorphic for the 129/Sv, C57BL/6 and NOD mice strains as described previously (20) , and the PCR products were detected and analyzed using 4% agarose gels. All animal procedures performed followed the Principles of Laboratory Animal Care (NIH publication 85-23, revised 1985), and were previously reviewed and approved by the YACUC (Yale Animal Care and Use Committee). When anesthesia was required, we used metoxy¯urane (Metofane) as a regulated inhalatory anesthetic.
Assessment of diabetes and immunohistochemical analysis
Female NOD/L-selectin KO (±/±), wild-type (+/+) or HTZ (+/±) littermates at the N7 or N14 generation were monitored weekly for the manifestation of glycosuria using Diastix (Ames, Elkhart, IN), starting at 7 weeks of age. Diabetes was con®rmed by measuring glycemia using One Touch test strips (Lifescan; Johnson & Johnson, Palmitas, CA) and values >250 mg/dl (>13.9 mM) were considered positive for diabetes. Pancreata were either ®xed in 10% buffered formalin or processed for immunohistochemistry by ®xation in paraformaldehyde±lysine±periodate buffer. In the former case the tissue was embedded in paraf®n, sectioned and stained with hematoxylin & eosin to examine the presence of mononuclear in®ltration in pancreatic islets (insulitis). For immunohistochemistry, after 16 h in paraformaldehyde± lysine±periodate buffer at 4°C the tissue was incubated in increasing concentrations of sucrose dissolved in phosphate buffer (10, 20 and 30%), embedded in Tissue-Tek OCT (Miles, Elkhart, IL) and frozen in 2-methylbutane (isopentane). Frozen sections (7 mm) were taken, and stained for insulin and glucagon [alkaline phosphatase kit; BioGenex, San Ramon, CA); for mouse CD4, CD8 and CD3 (PharMingen, San Diego, CA); and F4/80, as a marker of macrophages (Serotec, Raleigh, NC)]. The sections were incubated in the presence of alkaline phosphatase-conjugated streptavidin and subsequently in the presence of the HistoMark Red substrate (Kirkegaard & Perry, Gaithersburg, MD) for color development.
Adoptive transfer experiments
Immunocompromised NOD/SCID female mice (>4 weeks) were used as recipients of total splenocytes from NOD/Lselectin KO, wild-type or HTZ littermate donors, depending on the experiment. Total splenocytes were isolated under sterile conditions by physical disruption of the spleen using frosted glass slides, then red blood cells were lysed by hypotonic shock with distilled water. Cells were transferred in 200 ml of physiological saline (0.9% NaCl) by i.v. injection.
Sublethally irradiated NOD/L-selectin-de®cient (KO) orsuf®cient (HTZ) female mice between 6 and 8 weeks of age (725 rad/mouse) were used as recipients of in vitro activated TGNFC8 CD8 T cells (10 7 cells/mouse). Cells were transferred in 200 ml of physiological saline (0.9% NaCl) by i.v. injection.
Flow cytometric analysis of spleen cells
Splenocytes were isolated as described above and stained following standard procedures in PBS supplemented with 1% FBS. The antibodies used for¯ow cytometric analysis [CD4, CD8 and CD62L (L-selectin)] were directly conjugated to one of the following¯uorochromes: FITC, phycoerythrin or CyChrome (PharMingen). Splenocytes were incubated with Fig. 2 . NOD L-selectin-de®cient mice exhibit unaltered development of diabetes compared to wild-type littermates. (A) NOD/N7 Lselectin wild-type (+/+; ®lled squares; n = 10), HTZ (+/±; ®lled triangles; n = 18) and KO (±/±; ®lled circles; n = 13) females were monitored for the development of diabetes on a weekly basis starting at week 7 of age until week 35 of age. Once glycosuria was found, diabetes mellitus was con®rmed by determining the glycemia. The autoimmune condition was con®rmed by histological analysis of the pancreata. For statistical analysis, we applied the log-rank/Kaplan±Meier test (P < 0.05). (B) NOD/N7 L-selectinde®cient mice were backcrossed up the N14 generation, intercrossed and females [wild-type (+/+; ®lled squares; n = 22), HTZ (+/±; ®lled triangles; n = 14) and KO (±/±; ®lled circles; n = 9)] were observed up to 27 weeks of age for the development of diabetes. For statistical analysis, we applied the log-rank/Kaplan± Meier test (P < 0.05). Splenocytes from NOD/N7 L-selectin-de®cient mice transfer diabetes into NOD/SCID recipients with lower incidence and delayed kinetics compared to those from L-selectin-suf®cient littermates. Total splenocytes from 7-to 8-week-old pre-diabetic NOD/N7 L-selectin KO (±/±; open circles), wild-type (+/+; ®lled triangles) or HTZ (+/±; open triangles) female donors were isolated and adoptively transferred (15±20 Q 10 6 splenocytes per recipient mouse depending on the experiment) into 5-to 8-week-old NOD/ SCID recipients. Recipient mice were monitored for the development of diabetes every second day. The graph shown corresponds to data from three independent experiments. For statistical analysis, we applied the log-rank/Kaplan±Meier test (P < 0.05). (B) NOD/N11± 12 wild-type and L-selectin KO mice splenocytes adoptively transfer disease into NOD/SCID recipients similarly. NOD/SCID recipient females (5±6 weeks old) were adoptively transferred with either 15 Q 10 6 total splenocytes from either NOD/N11±12 L-selectin wild-type (+/+; ®lled rhomboids; n = 4) or KO (±/±; ®lled squares; n = 4) 11-week-old female donors. Diabetes was monitored every other day until day 115 after the adoptive transfer was performed. For statistical analysis, we applied the log-rank/Kaplan±Meier test (P < 0.05).
the corresponding antibody at 4°C for 30 min. After staining, the cells were analyzed on a FACS IV (Becton Dickinson Immunocytochemistry Systems, Mountain View, CA).
Statistical analysis
A log-rank/Kaplan±Meier test was applied to compare the cumulative incidence of diabetes (survival curve) between the different experimental groups studied. Differences were considered statistically signi®cant when P < 0.05. Statistical analyses were performed using SPSSwin software.
Results
Generation of NOD/L-selectin KO mice at N7, N11 and N14 L-selectin KO mice were generated by targeted disruption of the L-selectin (CD62L) locus and were backcrossed to the C57BL/6 background (11). We then backcrossed these mice onto the murine NOD autoimmune diabetes-prone genetic background. Mice which were selected to be homozygous for the 15 NOD Idd susceptibility alleles tested (Idd1±15) (20) were further backcrossed onto the NOD background to the six (N7), 10 (N11) and 13 (N14) generations respectively, and intercrossed at each of these three generations to obtain experimental mice. Only females were monitored for diabetes development. The L-selectin gene is located on mouse chromosome 1, relatively far (20±40 cM) from the Idd5 markers tested (D1Mit24, D1Mit26), and Idd5, as stated previously, was included in the set of the 15 Idd tested for NOD homozygosity. Total splenocytes from 8-week-old NOD/ L-selectin wild-type or KO N7 female mice were analyzed for the levels of L-selectin + cells, CD4 T cells and CD8 T cells. Spleen cells were stained for¯ow cytometry analysis of the CD4, CD8 and CD62L markers respectively. The levels of CD4 T cells and CD8 T cells in the spleen were not affected in the NOD/L-selectin KO mice, but expression of L-selectin was undetectable, as expected (45% of splenocytes in wild-type mice compared to 0.5% background levels in KO mice; data not shown).
Splenocytes from NOD/L-selectin KO mice transfer diabetes into NOD/SCID recipients
Since L-selectin enables naive lymphocytes to extravasate thorough HEV into peripheral lymph nodes and thus be primed, we assumed that peripheral naive autoaggressive lymphocytes in NOD/L-selectin-de®cient mice would contact pancreatic antigens for the ®rst time in the spleen rather than pancreatic lymph nodes. Therefore, at the age of 9 weeks, primed diabetogenic lymphocytes should be found in the spleen of both L-selectin-de®cient and -suf®cient NOD/N7 mice, since by this age we already observe insulitis in NOD/N7 L-selectin KO mice (see Fig. 3 ). To test this hypothesis, we performed adoptive transfer experiments using total splenocytes from 7-to 8-week-old NOD/N7 L-selectin wild-type, KO or HTZ female donors, transferred them into NOD/SCID female recipients and monitored the development of diabetes (Fig. 1A) . Interestingly, splenocytes from KO donors were able to transfer diabetes into immuno-compromised NOD/ SCID recipients with a signi®cant delay and lower diabetes incidence than that induced by wild-type donors (30% by the KO versus 90% wild-type and 100% HTZ). Since HTZ showed a signi®cant delay in transferring diabetes compared to wildtype donor splenocytes, there could be either a L-selectin gene dosage effect or incomplete NOD genetic background at the N7 backcross, which could also explain that the KO signi®cantly impaired transfer of diabetes. In agreement with the insuf®cient backcrossing hypothesis proposed above, when total spleen cells from pre-diabetic N11±12 wild-type donor were transferred into NOD/SCID recipients we observed that 100% of the recipient mice developed diabetes by day 110 following adoptive transfer. When splenocytes from a pre-diabetic NOD/N11KO donor were used, the incidence was also 100% at day 115 without exhibiting any signi®cant delay in disease transfer (see Fig. 1B ). This result is consistent with the hypothesis that the spleen constitutes an alternate route for priming of autoaggressive naive lymphocytes in the absence of a homing factor like L-selectin, although we did not observe the expected delayed kinetics compared to the natural peripheral lymphocyte route. These observations led us to study the spontaneous development of diabetes in NOD/ N7 L-selectin-de®cient mice, since a delay in autoaggressive lymphocyte priming via recruitment to the spleen should result in retardation in the onset of spontaneous rather than transferred disease.
NOD/L-selectin KO mice exhibit spontaneous development of IDDM and insulitis NOD/L-selectin KO, HTZ and wild-type females were monitored for the development of diabetes up to 35 weeks of age at the N7 generation and for 27 weeks at the N14 generation. While in the wild-type female group the cumulative incidence of diabetes was 80% by N7, the incidence was 39% in both the HTZ and KO groups respectively ( Fig. 2A) by 40 weeks of age. This difference in the cumulative incidence of diabetes was statistically signi®cant.
We examined pancreata from HTZ and KO N7 females by immunohistochemistry (Fig. 3) . Both NOD/N7 L-selectin KO and HTZ mice exhibited insulitis at 9 weeks of age. The in®ltrates observed included CD8 + cells, CD4 + T cells and some macrophages (Fig. 3) .
After monitoring the development of diabetes for almost 30 weeks in the N14 generation, no signi®cant difference either in the incidence or kinetics of spontaneous disease was observed between L-selectin-de®cient and -suf®cient in this generation. The cumulative incidence of diabetes in wild-type females remained unchanged after increasing the number of backcrosses (81% at N14 versus 80% at N7), KO females from the N14 generation reached 55% of individuals in the experimental group (compared to 39% at N7) and this was also the case for HTZ females (64% at N14 versus 39% at N7) (Fig. 2B) .
In vitro primed cloned autoaggressive TGNFC8 CD8 T cells show unimpaired homing into the pancreatic environment when adoptively transferred into NOD/L-selectin KO recipients
In order to con®rm that homing into pancreatic lymph nodes of already activated (non-naive) autoreactive T cells is not affected by the L-selectin de®ciency, we transferred 10 7 cells per mouse from the already described TGNFC8 autoaggressive, insulin-speci®c CD8 T cell clone (22) into either N7 L-selectin-suf®cient (HTZ) or N7-de®cient (KO) irradiated recipients. Homing into pancreatic lymph nodes was monitored by diabetes development on an every-day basis. In both experimental groups, diabetes onset occurred at similar rates and reached the same cumulative incidence (100% by day 10 after adoptive transfer) (Fig. 4) .
Discussion
L-selectin has been considered a target molecule for in the therapy of autoimmune diabetes, not only as an lymphocyte adhesion molecule susceptible to antagonism (17, 18) , but also as a marker of regulatory T cells (23) . Since the existing published data regarding the requirement of L-selectin for the induction of autoimmune diabetes relied on blocking speci®c anti-L-selectin antibodies in adoptively transferred diabetes models (17±19,24), we decided to study the role of L-selectin in autoimmune diabetes in NOD mice by ablating its expression via gene targeting. This method is capable of providing less equivocal results than blockade with speci®c antibodies, Fig. 4 . Homing of in vitro primed TGNFC8 insulin-speci®c CD8 T cells into the pancreatic environment is not altered in NOD/Lselectin-de®cient mice. Sublethally irradiated (725 rad) NOD/Lselectin KO (®lled circles, n = 7) or NOD/L-selectin HTZ (®lled squares, n = 5) female recipients were adoptively transferred with 10 7 TGNFC8 CD8 T cells/mouse and monitored for diabetes onset on a daily basis. For statistical analysis, we applied the log-rank/ Kaplan±Meier test (P < 0.05). Mouse tail DNA was isolated according to a standard procedure (22) , and using the above-mentioned set of primers we PCR ampli®ed fragments that are polymorphic for the strains 129/SV and NOD (Mouse Genome Informatics; Jackson Laboratory, Bar Harbor, ME). The PCR products were run in 4% agarose gels. The L-selectin gene is estimated to be located~86.6 cM from the acrocenter in mouse chromosome 1. a The marker D1Mit30 is not polymorphic for the NOD and C57BL/6 strains respectively. Mice #4 and 5 developed diabetes by 30 weeks of age.
since prolonged in vivo treatment could promote depletion of L-selectin + T or B cells. Our results reveal that the role of Lselectin in the initial homing of lymphocytes into the islets is not crucial for the development of autoimmune diabetes in NOD mice. Our results, including additional immunohistochemical and TGNFC8 clone information, are supported by those recently published by Friedline et al. (25) . In later phases, it is possible that the requirement for L-selectin may be overridden by other adhesion factors, very probably VLA4-VCAM (19) , since young pre-diabetic NOD/L-selectin-de®-cient female mice exhibit islet in®ltrates similar to those in Lselectin-suf®cient (HTZ) females. The fact that the diabetogenic capabilities of splenocytes from L-selectin-de®cient and -suf®cient mice are similar could be interpreted as an enrichment in fully diabetogenic T cells in the spleen from pre-diabetic donors. This observation is consistent with what has been previously observed using different lymphoid organs as a source of diabetogenic lymphocytes: bone marrow and spleen recruit higher frequencies of diabetogenic T cells than the blood (27) . A statistically signi®cant difference in diabetes onset was observed between NOD/N7 wild-type (80%) and KO/HTZ (39%). This impairment in diabetes development was not observed at the N14 generation in KO (55%) or HTZ (64%) compared to wild-type (81%). Further backcrossing into the NOD genetic background rescued the diabetic phenotype in NOD/N14 KO and NOD/N14 HTZ mice. Surprisingly it seems that the resistance allele(s) map outside the L-selectin genetic interval comprehended between 86.6 and 87.8 cM (L-selectin maps to 86.6 cM in chromosome 1), since NOD/N14 HTZ mice also heterozygous for the NOD markers in this region developed diabetes (preliminary results; see Table 1 ). Therefore, L-selectin plays a minor role in the development of autoimmune diabetes in NOD mice and this role may be shared with a resistance locus, probably not in the close vicinity of the L-selectin gene, that persists even after thorough backcrossing.
In summary, we propose a scenario in which the presence of L-selectin on the surface of naive lymphocytes would facilitate the rolling and extravasation of diabetogenic lymphocytes in early phases of diabetes. In¯ammation signals would up-regulate the expression of addressins on islet vessels (26) which would augment the lymphocyte recruitment process. In the absence of L-selectin, naive T cells would be primed elsewhere (likely in the spleen) or in the pancreatic lymph node via entry using alternative adhesion molecules (such as a 4 integrins). The results presented in our work suggest the necessity to study lymphocytic adhesion molecules other than L-selectin such as VLA4 in order to effectively prevent the development of diabetes.
